A Randomized, Double-Blind, Placebo-Controlled, Parallel

Project: Research project

Description

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BMS-986168 in Participants with Progressive Supranuclear Palsy
StatusFinished
Effective start/end date1/18/171/31/20

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint

Progressive Supranuclear Palsy
Placebos
Safety